| METFORMIN | Small molecule | gestational diabetes | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | bipolar disorder | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | metabolic syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | colorectal adenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | obesity | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | systolic heart failure | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | Bardet-Biedl syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | neuropathic pain | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | chronic kidney disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | gestational diabetes | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | adenosquamous lung carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | metabolic syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | small cell lung carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | non-alcoholic fatty liver disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | breast cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | obesity | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | non-small cell lung carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | aging | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Suspended | ClinicalTrials |
| METFORMIN | Small molecule | neoplasm of thorax | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | Cognitive impairment | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | urinary bladder cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | breast cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Suspended | ClinicalTrials |
| METFORMIN | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | ovarian clear cell cystadenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Suspended | ClinicalTrials |
| METFORMIN | Small molecule | ovarian cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | prostate cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | freckles | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | insulin resistance | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | pancreatic carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | Elevated hepatic transaminase | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | large cell lung carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | muscular dystrophy | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | intermittent vascular claudication | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | burn | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Unknown status | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | oral squamous cell carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | Endometrial Intraepithelial Neoplasia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | obesity | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | obesity | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | lupus nephritis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | Barrett's esophagus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | metastatic melanoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | Abdominal Aortic Aneurysm | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Enrolling by invitation | ClinicalTrials |
| METFORMIN | Small molecule | fallopian tube cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Suspended | ClinicalTrials |
| METFORMIN | Small molecule | hepatocellular carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | pancreatic ductal adenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | Endometrial Hyperplasia without Atypia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | head and neck malignant neoplasia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | aging | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | Hypercholesterolemia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | prediabetes syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | brain ischemia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | periodontitis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | Hyperinsulinemia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | non-alcoholic fatty liver disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | gestational diabetes | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | colorectal carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Terminated | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | fallopian tube cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Suspended | ClinicalTrials |
| METFORMIN | Small molecule | HIV infection | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | Malignant Ovarian Brenner Tumor | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Suspended | ClinicalTrials |
| METFORMIN | Small molecule | altitude sickness | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | ovarian cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | endometrial cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | Intellectual disability | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | adenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | cervical adenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | Peri-Implantitis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | lung cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | breast ductal carcinoma in situ | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | body weight gain | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | breast cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | head and neck malignant neoplasia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | diabetic neuropathy | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | Autosomal dominant polycystic kidney disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | insulin resistance | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Withdrawn | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | chronic kidney disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | prediabetes syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | Thiamine deficiency | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | Huntington disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | prostate cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | non-small cell lung carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | breast cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | infertility | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | acute coronary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | malignant colon neoplasm | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | insulin resistance | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | oral squamous cell carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | heart failure | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | spastic cerebral palsy | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | bipolar disorder | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | systemic lupus erythematosus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | prostate cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | aging | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | chronic obstructive pulmonary disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | acanthosis nigricans | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | Duchenne muscular dystrophy | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | peritoneum cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Suspended | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | COVID-19 | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | atrial fibrillation | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | insulin resistance | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | neuroendocrine neoplasm | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | primary peritoneal carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | pancreatic adenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | Vitiligo | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | malignant colon neoplasm | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | body weight gain | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | breast cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | HIV infection | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | non-alcoholic steatohepatitis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | colorectal carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | coronary artery disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | endometrial carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | rectum cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | prediabetes syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | sex chromosome disorder of sex development | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | endometrial cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | head and neck squamous cell carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | prostate cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | oral squamous cell carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Withdrawn | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | obesity | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | diabetes insipidus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | sickle cell anemia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | metastatic prostate cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | rheumatoid arthritis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | Vitiligo | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | Hepatitis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 1 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | chronic kidney disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | prostate adenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | multiple myeloma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | gliosarcoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | chronic hepatitis C virus infection | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | prostate cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | fragile X syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| ME-344 | Small molecule | neoplasm | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | ovarian carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | non-alcoholic fatty liver disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | diabetic neuropathy | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | follicular lymphoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | Stargardt disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | liver cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | glioblastoma multiforme | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | inflammatory bowel disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | infertility | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | aging | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | head and neck squamous cell carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | lung carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | obesity | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | intermittent vascular claudication | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | hepatocellular carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Terminated | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | diabetic foot | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | mouth neoplasm | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | prostate carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | Hepatic steatosis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | prostate cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | obesity | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | rectum cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | breast cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | amenorrhea | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | neoplasm | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | neoplasm | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | non-alcoholic steatohepatitis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | gliosarcoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | leprosy | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | insulin resistance | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | non-alcoholic fatty liver disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | urogenital neoplasm | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | - | DailyMed |
| METFORMIN HYDROCHLORIDE | Small molecule | Ovarian Germ Cell Tumor | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | Low back pain | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | Familial adenomatous polyposis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | atherosclerosis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | Myocardial fibrosis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | type 1 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | obesity | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | ovarian serous cystadenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | metabolic disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | hepatitis C virus infection | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | gestational diabetes | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | schizophrenia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | obesity | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | prediabetes syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | pulmonary arterial hypertension | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | bipolar disorder | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | hypertension | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | pregnancy | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | endometrial carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | fragile X syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | acute lymphoblastic leukemia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | endometrioid carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Suspended | ClinicalTrials |
| METFORMIN | Small molecule | Cognitive impairment | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | breast carcinoma in situ | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | multiple myeloma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | Li-Fraumeni syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | schizoaffective disorder | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | ovarian serous cystadenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Suspended | ClinicalTrials |
| METFORMIN | Small molecule | malaria | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | schizoaffective disorder | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | lung adenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | squamous cell carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | melanoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | pregnancy | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | neoplasm | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | schizophrenia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Terminated | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | ovarian serous cystadenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | glaucoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | metabolic syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | diffuse large B-cell lymphoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | breast cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | pancreatic neuroendocrine tumor | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | Autosomal dominant polycystic kidney disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | Intellectual disability | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | urinary bladder cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | diffuse large B-cell lymphoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | prostate carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | diffuse large B-cell lymphoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | obesity | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Suspended | ClinicalTrials |
| METFORMIN | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | ischemia reperfusion injury | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | glioblastoma multiforme | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | pancreatic ductal adenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | pancreatic adenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 1 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | prediabetes syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Unknown status | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | Ascites | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Suspended | ClinicalTrials |
| METFORMIN | Small molecule | endometrial cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | lung adenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | neurobehavioral manifestations | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | gestational diabetes | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | prediabetes syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | breast cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | prostate cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | insulin resistance | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | Endometrial Intraepithelial Neoplasia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | cervical cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | - | ATC,DailyMed |
| METFORMIN | Small molecule | Hepatic steatosis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Terminated | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | ovarian clear cell cystadenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Suspended | ClinicalTrials |
| METFORMIN | Small molecule | peripheral neuropathy | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | obstructive sleep apnea | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | major depressive disorder | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | prostate adenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | non-small cell lung carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | prostate cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | liver disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | pancreatic adenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | Mental deterioration | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | inflammation | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | melanoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Terminated | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | heart failure | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | breast cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | malignant colon neoplasm | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | glioblastoma multiforme | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | hypertension | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | infertility | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | squamous cell carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | chronic kidney disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | fallopian tube cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | osteoarthritis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | prostate cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | pancreatic carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | Abdominal Aortic Aneurysm | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | Malignant Ovarian Brenner Tumor | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Suspended | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | diabetic foot | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | prostate cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | chronic lymphocytic leukemia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | body weight gain | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | inflammation | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | rheumatoid arthritis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | obesity | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Suspended | ClinicalTrials |
| METFORMIN | Small molecule | colorectal neoplasm | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | metastatic colorectal cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | glioblastoma multiforme | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | prostate carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | COVID-19 | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | chronic hepatitis C virus infection | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | bronchoalveolar adenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | pancreatic adenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | HIV-Associated Lipodystrophy Syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | multiple myeloma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | endothelial dysfunction | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | depressive disorder | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | type 1 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | hypertension | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | prostate cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | inflammatory bowel disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | prostate adenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Suspended | ClinicalTrials |
| METFORMIN | Small molecule | prostate cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | pulmonary arterial hypertension | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | gestational diabetes | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | hidradenitis suppurativa | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | Cognitive impairment | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | prostate carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | Abnormal blood glucose concentration | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | peritoneum cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Suspended | ClinicalTrials |
| METFORMIN | Small molecule | endometrial cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | body weight gain | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | endometrial cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | metabolic syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | obesity | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | esophageal squamous cell carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | oropharynx squamous cell carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | metabolic syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | atrophic macular degeneration | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Withdrawn | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | Ovarian Germ Cell Tumor | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Suspended | ClinicalTrials |
| METFORMIN | Small molecule | systolic heart failure | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | prostate cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | pancreatic carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | peripheral arterial disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | primary progressive multiple sclerosis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | prediabetes syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | sex chromosome disorder of sex development | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | cardiovascular disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | lung carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | physical activity | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | non-small cell lung carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | atrial fibrillation | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | prediabetes syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | multiple sclerosis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | metabolic syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | endometrioid carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Suspended | ClinicalTrials |
| METFORMIN | Small molecule | gestational diabetes | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Withdrawn | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | - | DailyMed,FDA |
| METFORMIN | Small molecule | frontotemporal dementia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | metastatic prostate cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | Stargardt disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | Fanconi anemia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | Ovarian Germ Cell Tumor | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Suspended | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | muscular dystrophy | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | abnormal glucose tolerance | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | breast cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | tuberculosis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | gestational diabetes | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | neuroendocrine neoplasm | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | schizophrenia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | fragile X syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | infertility | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | Disorder of lipid metabolism | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | pleural effusion | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Suspended | ClinicalTrials |
| METFORMIN | Small molecule | Endometrial Hyperplasia without Atypia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | chronic obstructive pulmonary disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | non-small cell lung carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | heart failure | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | triple-negative breast cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | prediabetes syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | Hepatic steatosis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | Fanconi anemia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Enrolling by invitation | ClinicalTrials |
| METFORMIN | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Enrolling by invitation | ClinicalTrials |
| METFORMIN | Small molecule | glioblastoma multiforme | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | aging | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | pancreatic carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | Ataxia-telangiectasia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | Disorder of lipid metabolism | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | diabetic retinopathy | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | chronic kidney disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | blindness (disorder) | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | abnormal glucose tolerance | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | pancreatic carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | non-small cell lung carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | neurobehavioral manifestations | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | Ascites | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Suspended | ClinicalTrials |
| ME-344 | Small molecule | neoplasm | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Terminated | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | prostate carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | prostate cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | gestational diabetes | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | secondary progressive multiple sclerosis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | Endometrial Hyperplasia without Atypia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | infertility | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | obesity | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | non-small cell lung carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 1 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Withdrawn | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | malignant colon neoplasm | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | breast carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | lung adenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | mental or behavioural disorder | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | brain ischemia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | multiple sclerosis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | angiosarcoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | ovarian serous cystadenocarcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Suspended | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | Hepatic steatosis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | metabolic disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | brain neoplasm | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Terminated | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | pancreatic carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | Hyperinsulinemia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | schizophrenia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | obesity | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | obesity | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | Ovarian Germ Cell Tumor | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | breast cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | fragile X syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | endometrial cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | habitual abortion | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Withdrawn | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | peritoneum cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | breast cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | breast cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | breast ductal carcinoma in situ | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | type 2 diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | - | DailyMed,FDA |
| METFORMIN | Small molecule | periodontitis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | ulcerative colitis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | metabolic syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | severe acute respiratory syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | non-alcoholic fatty liver disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | obesity | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | head and neck malignant neoplasia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | pleural effusion | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Suspended | ClinicalTrials |
| ME-344 | Small molecule | breast carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | obesity | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | mouth neoplasm | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | bone fracture | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | generalized anxiety disorder | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Terminated | ClinicalTrials |
| METFORMIN | Small molecule | diabetes mellitus | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | polycystic ovary syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | fallopian tube cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | brain neoplasm | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | migraine disorder | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | coronary artery disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN HYDROCHLORIDE | Small molecule | non-small cell lung carcinoma | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | peripheral arterial disease | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| METFORMIN | Small molecule | head and neck malignant neoplasia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 0.5 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | Cognitive impairment | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | peritoneum cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | psoriasis | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Unknown status | ClinicalTrials |
| METFORMIN | Small molecule | acne | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | gestational diabetes | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | aging | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 1.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | thyroid cancer | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| METFORMIN | Small molecule | schizophrenia | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Withdrawn | ClinicalTrials |
| METFORMIN | Small molecule | metabolic syndrome | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 4.0 | Active, not recruiting | ClinicalTrials |
| METFORMIN | Small molecule | gestational diabetes | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 2.0 | Completed | ClinicalTrials |
| METFORMIN | Small molecule | brain neoplasm | Mitochondrial complex I (NADH dehydrogenase) inhibitor | 3.0 | Completed | ClinicalTrials |